SimonMed
SimonMed is a U.S. outpatient diagnostic imaging operator running 170+ accredited centers across 10 states, offering MRI, CT, mammography, and AI-enhanced add-on services, plus a direct-to-consumer SimonMed Longevity preventive-screening division powered by 3T MRI technology.
- Company typePrivate
- Founded2003
- HeadquartersScottsdale, United States
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What SimonMed does
SimonMed is a U.S.-based outpatient medical imaging operator founded in 2003 by Dr. John Simon and headquartered in Scottsdale, Arizona. The company runs 170+ accredited imaging centers across 10 states (Arizona, California, Colorado, Florida, Illinois, Kentucky, Nevada, New York, Texas, Wisconsin), employing 200-300+ subspecialty-trained radiologists who have cumulatively read more than 40 million scans. Service lines span MRI, CT, X-ray, 3D mammography, breast MRI, ultrasound, PET/CT, nuclear medicine, DEXA bone density, and cardiac imaging, supplemented by mobile on-site mammography for employer outreach.
The technology stack is built around an AI-enhanced imaging platform that integrates multiple FDA-cleared third-party models enterprise-wide: AIRS Medical's SwiftMR for MRI image enhancement and scan-time reduction; Lunit's foundation models for chest X-ray report generation (fine-tuned on SimonMed's imaging data); and proprietary opportunistic-screening AI add-ons (Calcium Score+, CT Bone Density, MR Lumbar Spine+, Mammogram+, Mammogram+ Heart, Thyroid Ultrasound+, Breast Ultrasound+, CCTA with AI Plaque Analysis, DEXA+TBS). A new SimonMed Longevity division launched in February 2026 offers direct-to-consumer whole-body MRI and multi-modality preventive screening packages without requiring a physician referral, expanding outside the traditional insurance-reimbursed referral channel.
Revenue is generated primarily through per-exam diagnostic imaging fees reimbursed by commercial insurers, Medicare, Medicaid, and workers' compensation, with out-of-pocket patient payments at the time of service. A growing high-margin layer comes from AI-enhanced add-on services priced at $40-$50 per exam (bundled pricing available), plus self-pay preventive longevity packages supported by CareCredit, Klarna, and Affirm financing. Patient acquisition combines direct consumer channels (website, phone, chat, online booking via OpenDr) with B2B referrals from physicians, hospitals, health systems, and corporate on-site mammography contracts. Additional enterprise/B2B revenue is generated through partnerships such as the commercial deployment of 4DMedical's CT:VQ lung imaging software across SimonMed's outpatient footprint.
SimonMed firmographics
Firmographics- Name
- SimonMed
- Legal name
- SimonMed Imaging MSO, LLC
- Website
- https://simonmed.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- SimonMed is a U.S. outpatient diagnostic imaging operator running 170+ accredited centers across 10 states, offering MRI, CT, mammography, and AI-enhanced add-on services, plus a direct-to-consumer SimonMed Longevity preventive-screening division powered by 3T MRI technology.
- Ownership category
- akta.pro rank
SimonMed industry classification
Industry- Product category
- Outpatient Diagnostic Imaging
- NAICS
- Diagnostic Imaging Centers (621512)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA)
Keywords
Where SimonMed is headquartered
LocationHeadquarters
- HQ city
- Scottsdale
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SimonMed business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Diagnostic Imaging Services: Core revenue from providing diagnostic imaging services (MRI, CT, X-ray, mammography, ultrasound, PET/CT, nuclear medicine) to patients referred by healthcare providers. Revenue generated through insurance reimbursements and patient payments at time of service.
- AI-Enhanced Add-on Services: Premium AI-enhanced imaging services offered as add-ons to standard diagnostic scans, with additional out-of-pocket charges ranging from $40 to $50 per service, including bundled pricing options.
- SimonMed Longevity Screening: Direct-to-consumer preventive health screening packages including whole-body MRI and enhanced screening services powered by 3T MRI technology, targeting health-conscious consumers seeking proactive health insights.
- Personal Injury Imaging: Specialized imaging services for personal injury cases, including legal documentation and reports for attorneys and insurance purposes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | AI-Enhanced Add-on Services |
| Unit Pricing | Pay-as-you-go | No-Show Fee |
| Unit Pricing | Pay-as-you-go | Credit Card Processing Fee |
| Unit Pricing | Pay-as-you-go | Medical Records CD |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
SimonMed product offering
Product offeringCore offering
SimonMed operates a national network of outpatient diagnostic imaging centers providing MRI, CT, X-ray, mammography, ultrasound, PET/CT, nuclear medicine, and DEXA bone density scans, with reads delivered by subspecialty-trained radiologists. It augments these core scans with separately priced AI-powered diagnostic add-ons (e.g., Calcium Score+, Mammogram+, CCTA with AI Plaque Analysis) and operates a preventive whole-body MRI program under the SimonMed Longevity sub-brand, plus a mobile on-site mammography service.
Product overview
SimonMed is a large U.S.-based outpatient imaging provider offering a comprehensive portfolio of diagnostic imaging services across 170+ locations in 10 states. The company operates a hub-and-spoke model with its core diagnostic services (MRI, CT, X-ray, mammography, ultrasound, PET/CT, nuclear medicine, DEXA) forming the foundation, supplemented by an expanding suite of AI-enhanced add-on services. Key AI-powered offerings include Calcium Score+, CT Bone Density, MR Lumbar Spine+, Mammogram+, Mammogram+ Heart, and CCTA with AI Plaque Analysis—these modules leverage FDA-cleared AI to extract additional quantitative diagnostic information from standard imaging studies. SimonMed Longevity serves as the preventive care sub-brand offering whole-body MRI and enhanced multi-modality screening packages powered by 3T MRI technology. The company integrates third-party AI technologies including AIRS Medical's SwiftMR for MRI enhancement, Lunit's foundation models for chest X-ray reporting, and Cascaid Health's Digital Health Platform for patient result delivery. SimonMed has also launched a pilot of EndomAI (from partner Matricis.ai) for endometriosis detection on MRI.
Differentiator
Problem solved
Functional benefit
Brands
- SimonMed Longevity: Division dedicated to AI-enabled preventive care and longevity screening, offering whole-body MRI and multi-modality screening packages powered by 3T MRI technology
- simonONE
- MagView
Quantifiable outcome
- 40+ million scans read by expert radiologist team
- +3 more outcomes
Companies that use SimonMed
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
SimonMed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability11 records
Feature9 records
SimonMed partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- 4DMedicalcore4DMedical secured FDA 510(k) clearance for its CT:VQ lung imaging software and signed a commercial contract with SimonMed for deployment in the US outpatient imaging market. This partnership expands SimonMed's lung imaging capabilities and establishes 4DMedical's commercial footprint in the US outpatient market, with an estimated addressable market of approximately US$3.00 billion.
- AIRS MedicalcoreEnterprise-wide deployment of AIRS Medical's FDA-cleared SwiftMR AI solution across SimonMed's nationwide network of MRI scanners. The technology improves image clarity, reduces scan times, and enhances workflow efficiency through vendor-neutral architecture without additional hardware investment.
- Matricis.aiminorClinical collaboration to launch the first US pilot of EndomAI, an AI platform designed to assist radiologists in detecting endometriosis from MRI scans. The pilot will enroll approximately 200 patients at select SimonMed centers to assess diagnostic consistency, lesion detection, and radiologist confidence. Collaboration addresses the average 7-10 year diagnostic delay for endometriosis.
- LunitcoreStrategic partnership to deploy large-scale custom foundation models for chest X-ray report generation across SimonMed's 175+ locations. SimonMed will fine-tune AI models using its own imaging data within a HIPAA-compliant environment through Lunit's Foundation Model Services platform to improve reporting quality, speed, and standardization. Expansion to mammography models planned for 2026.
- Cascaid HealthcoreClinical partnership providing personalized, fully supported screening experience for patients receiving select enhanced services. Cascaid Health provides interactive mobile reports, tailored action plans, and dedicated patient navigators to help patients understand results and coordinate next steps through a Digital Health Platform.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
SimonMed competitors and assessment
Company assessmentDirect peers
- RadNet: RadNet is the largest U.S. outpatient diagnostic imaging operator with 370+ centers across multiple states. It is a direct competitor offering MRI, CT, mammography, ultrasound, and increasingly AI-enhanced services (including its DeepHealth AI subsidiary), with a publicly listed scale comparable to SimonMed.
- Akumin: Akumin is a national outpatient imaging and radiology services provider operating fixed-site centers and mobile units across the U.S. It directly competes with SimonMed in MRI, CT, PET/CT, and women's imaging services.
- Envision Radiology: Envision Radiology is a multi-state outpatient imaging provider offering diagnostic imaging, pain management, and women's health services. It competes directly with SimonMed's outpatient center model across overlapping states.
Emerging players
- Prenuvo: Prenuvo is a venture-backed preventive whole-body MRI screening company targeting health-conscious consumers — the same DTC longevity market SimonMed Longevity is pursuing with its whole-body MRI offering.
- Ezra: Ezra is an early-stage direct-to-consumer whole-body MRI screening company using AI to make preventive imaging faster and more affordable. It competes with SimonMed Longevity's SimonONE/simonONE Whole-Body MRI offering.
Broad incumbents
- GE HealthCare: GE HealthCare is a global medical imaging equipment manufacturer and AI/imaging informatics provider. It supplies the MRI, CT, and AI platforms that SimonMed and its competitors deploy, and competes broadly in enterprise imaging.
- Siemens Healthineers: Siemens Healthineers is a global medical technology company offering imaging equipment (MRI, CT, X-ray) and digital health solutions. As a major equipment vendor to SimonMed and competing imaging centers, it shapes the technology landscape in which SimonMed operates.
- Koninklijke Philips: Philips is a global health technology company with a major diagnostic imaging and imaging informatics business. It provides equipment and software platforms used across the outpatient imaging industry and competes in adjacent digital health and AI imaging solutions.
- Hologic: Hologic is a women's health-focused medical technology company that manufactures mammography systems (including 3D tomosynthesis). It supplies the breast imaging equipment SimonMed uses and is a key competitor/partner in the women's imaging segment.
Others
- iCAD: iCAD provides AI-powered breast health and prostate cancer detection solutions that integrate with mammography and MRI workflows. As an AI vendor ecosystem partner, it represents the type of AI technology SimonMed may deploy or compete against in women's imaging.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
SimonMed social profiles
Digital presenceSimonMed compliance and trust
Trust signalCompliance7 records
SimonMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
SimonMed leadership team
Management profileNumber of profiles
SimonMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SimonMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SimonMed
What does SimonMed do?
SimonMed operates a national network of outpatient diagnostic imaging centers providing MRI, CT, X-ray, mammography, ultrasound, PET/CT, nuclear medicine, and DEXA bone density scans, with reads delivered by subspecialty-trained radiologists. It augments these core scans with separately priced AI-powered diagnostic add-ons (e.g., Calcium Score+, Mammogram+, CCTA with AI Plaque Analysis) and operates a preventive whole-body MRI program under the SimonMed Longevity sub-brand, plus a mobile on-site mammography service.
Is SimonMed a public or private company?
SimonMed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SimonMed founded?
SimonMed was founded in 2003. It employs 1,001 to 5,000 people.
Where is SimonMed based?
SimonMed is headquartered in Scottsdale, United States, in the North America region.
How does SimonMed make money?
Four revenue lines are on record. Diagnostic Imaging Services are the primary driver. The others are AI-Enhanced Add-on Services, simonMed Longevity Screening and personal Injury Imaging.
Who are SimonMed's main competitors?
Direct peers on record are RadNet, Akumin and Envision Radiology. Emerging players are Prenuvo and Ezra. Broad incumbents are GE HealthCare, Siemens Healthineers, Koninklijke Philips and Hologic. iCAD is listed as an others.
Does SimonMed have an API?
No public API is recorded for SimonMed.
What industry is SimonMed in?
SimonMed's product category is Outpatient Diagnostic Imaging. Its primary akta.pro industry code is HLAFAKAA, Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound). Its NAICS code is 621512 and its SIC code is 8011.